# Amlodipine for Myocardial Iron in Thalassemia

> **NCT02065492** · PHASE2,PHASE3 · COMPLETED · sponsor: **Aga Khan University** · enrollment: 20 (actual)

## Conditions studied

- Thalassemia

## Interventions

- **DRUG:** Standard Chelation
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT02065492
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02065492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02065492, "Amlodipine for Myocardial Iron in Thalassemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02065492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*